Ivabradine in the treatment of systolic heart failure - A systematic review and meta-analysis

doi:10.4330/wjc.v9.i2.182

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7586)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-8) series, Tables (1-1) series.

Item

Count

PDF

594

WORD

312

HTML

4319

Figures (1-8)

159

Tables (1-1)

156

Sum=5540

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

865

Download

1181

Sum=2046

Feb 26, 2017 (publication date) through Apr 28, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Cardiol. Feb 26, 2017; 9(2): 182-190
Published online Feb 26, 2017. doi: 10.4330/wjc.v9.i2.182

Full Size Figure Download Figure

Figure 8 Comparison of difference in means of ejection fraction between ivabradine + beta-blocker vs beta-blocker alone. BB: Beta blockers.

Citation: Anantha Narayanan M, Reddy YNV, Baskaran J, Deshmukh A, Benditt DG, Raveendran G. Ivabradine in the treatment of systolic heart failure - A systematic review and meta-analysis. World J Cardiol 2017; 9(2): 182-190
URL: https://www.wjgnet.com/1949-8462/full/v9/i2/182.htm
DOI: https://dx.doi.org/10.4330/wjc.v9.i2.182